Berlin - Delayed Quote EUR
Viking Therapeutics Inc (1VT.BE)
24.62
+0.20
+(0.84%)
As of 11:00:02 AM GMT+2. Market Open.
Key Executives
Key Executives Information Not Available
Viking Therapeutics Inc
Profile Information Not Available
Description
Description Information Not Available
Corporate Governance
Viking Therapeutics Inc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
July 22, 2025 at 10:59 AM UTC - July 28, 2025 at 12:00 PM UTC
Viking Therapeutics Inc Earnings Date
Recent Events
Recent Events Information Not Available
Related Tickers
F6T.DU Fate Therapeutics Inc
0.8576
-6.60%
1CVAC.MI CureVac N.V.
3.1580
+3.20%
CSJA.F CSL Limited
68.00
+2.26%
9LB.MU Legend Biotech Corp
25.00
-0.79%
0O2.SG Sagimet Biosciences Inc
2.9200
0.00%
1TB0.SG Orphazyme AS
137.50
0.00%
GENSY Genus plc
24.34
-12.45%
P0F.F Egetis Therapeutics AB (publ)
0.2820
-5.21%
328.SG MeiraGTx Holdings PLC
4.4200
+1.38%
YDO1.F Madrigal Pharmaceuticals, Inc.
257.70
-0.19%